Discover the Innovative BPC-157 Peptide Treatment Thats Gaining Attention
The statement is the first to provide recommendations for perioperative management of patients taking GLP-1 RAs based on an in-depth systematic literature review of both clinical perioperative studies and gastric emptying data, Adriana Oprea, MD, the first author of the document, and her colleagues wrote
In addition, the researchers said those taking the GLP-1 drugs also experienced decreased risks of suicidal ideation, self-harm, bulimia and psychotic disorders such as schizophrenia
However, delaying structured treatment may allow obesity-related conditions to progress
Although some studies have demonstrated benefits such as increased lean body mass and improved body composition (in populations with clinical need for the drugs), these gains have not consistently translated into enhancements in muscle strength, physical performance, or overall quality of life
Consult licensed healthcare providers